HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Murota Selected Research

2-aminoethylamide N- ((2- (hydroxyaminocarbonyl)methyl)- 4- methylpentanoyl)- 3- (2'- naphthyl)alanylalanine

1/2010Tumor necrosis factor-alpha processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Murota Research Topics

Disease

27Atopic Dermatitis (Atopic Eczema)
12/2023 - 10/2011
13Inflammation (Inflammations)
10/2022 - 09/2008
10Skin Diseases (Skin Disease)
01/2023 - 07/2003
9Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 11/2013
8Hypersensitivity (Allergy)
01/2023 - 12/2007
7Pruritus (Itching)
09/2021 - 08/2009
6Dermatitis
01/2023 - 08/2009
5Systemic Scleroderma (Systemic Sclerosis)
01/2023 - 01/2010
5Eczema
05/2021 - 09/2011
5Urticaria (Hives)
11/2019 - 12/2007
4Prurigo
04/2024 - 08/2009
4Hypohidrosis
07/2023 - 02/2014
4Fibrosis (Cirrhosis)
01/2019 - 08/2009
4Neoplasms (Cancer)
08/2015 - 01/2003
4Sclerosis
08/2015 - 01/2012
3Infections
03/2022 - 11/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2020 - 11/2003
3Melanoma (Melanoma, Malignant)
12/2017 - 07/2014
2Pain (Aches)
06/2023 - 12/2009
2Myositis (Idiopathic Inflammatory Myopathies)
02/2022 - 01/2022
2Rheumatoid Arthritis
01/2022 - 03/2015
2Wounds and Injuries (Trauma)
10/2020 - 05/2012
2Tuberous Sclerosis (Bourneville's Disease)
08/2020 - 01/2018
2Chronic Urticaria
11/2019 - 12/2009
2Chronic Kidney Failure (Chronic Renal Failure)
02/2019 - 12/2010
2Pancreatitis
01/2018 - 11/2011
2Contact Dermatitis (Eczema, Contact)
12/2016 - 01/2014
2Annular Erythema
08/2015 - 04/2014
2Neoplasm Metastasis (Metastasis)
08/2015 - 07/2012
2Seborrheic Keratosis
06/2015 - 02/2013
2Exfoliative Dermatitis (Erythroderma)
01/2015 - 06/2006
2Vitiligo
03/2012 - 07/2003
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2024

Drug/Important Bio-Agent (IBA)

9Ointments (Pastes)IBA
10/2022 - 07/2003
8Adrenal Cortex Hormones (Corticosteroids)IBA
04/2024 - 09/2011
8PeriostinIBA
09/2020 - 01/2012
7Histamine (Histamine Dihydrochloride)FDA Link
06/2023 - 01/2009
7CytokinesIBA
01/2020 - 09/2008
6Interleukin-17 (Interleukin 17)IBA
01/2023 - 11/2013
6Tacrolimus (Prograf)FDA LinkGeneric
10/2022 - 04/2010
5EmollientsIBA
10/2022 - 10/2016
5AutoantibodiesIBA
02/2022 - 01/2012
5Immunoglobulin E (IgE)IBA
10/2021 - 01/2010
5Histamine Antagonists (Antihistamines)IBA
09/2021 - 01/2009
4AntigensIBA
01/2023 - 08/2014
4Messenger RNA (mRNA)IBA
11/2019 - 01/2003
3Janus Kinase InhibitorsIBA
12/2023 - 03/2022
3upadacitinibIBA
12/2023 - 03/2022
3EnzymesIBA
01/2023 - 02/2013
3Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2003
3Histamine H1 Receptors (Histamine H1 Receptor)IBA
09/2021 - 10/2011
3Sirolimus (Rapamycin)FDA Link
08/2020 - 08/2014
3Glucose (Dextrose)FDA LinkGeneric
12/2019 - 01/2018
3IntegrinsIBA
11/2019 - 05/2012
3HaptensIBA
12/2016 - 01/2014
3CollagenIBA
08/2014 - 06/2013
3Interleukin-6 (Interleukin 6)IBA
01/2012 - 09/2008
2nemolizumabIBA
04/2024 - 08/2021
2dupilumabIBA
01/2023 - 09/2020
2Claudin-1IBA
01/2023 - 12/2016
2Claudin-3IBA
01/2023 - 01/2018
2delgocitinibIBA
10/2022 - 10/2022
2CeramidesIBA
10/2022 - 11/2013
2HLA-DR Antigens (HLA-DR)IBA
02/2022 - 01/2022
2Immunoglobulin G (IgG)IBA
02/2022 - 01/2022
2AntibodiesIBA
01/2022 - 02/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2020 - 07/2012
2Interleukin-22 (IL-22)IBA
09/2020 - 11/2013
2LigandsIBA
09/2020 - 11/2019
2trans-sodium crocetinate (crocetin)IBA
08/2020 - 01/2018
2Filaggrin ProteinsIBA
08/2020 - 04/2015
2Intravenous Immunoglobulins (IVIG)FDA Link
09/2017 - 06/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2016 - 01/2010
2Oxidoreductases (Dehydrogenase)IBA
01/2016 - 01/2016
2OxazoloneIBA
01/2016 - 01/2014
2CorticosteroneIBA
01/2016 - 01/2016
2alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
08/2015 - 07/2012
2Polysaccharides (Glycans)IBA
08/2015 - 07/2012
2AcetylglucosamineIBA
08/2015 - 07/2012
2OligosaccharidesIBA
08/2015 - 07/2012
2tocilizumab (atlizumab)FDA Link
03/2015 - 12/2010
2Chemokine CCL17IBA
01/2015 - 09/2012
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2014 - 02/2013
2Olopatadine Hydrochloride (Patanol)FDA Link
01/2014 - 01/2010
2Substance PIBA
09/2012 - 01/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2012 - 01/2010
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2012 - 01/2010
2C-Reactive ProteinIBA
12/2009 - 09/2008
2Prednisolone (Predate)FDA LinkGeneric
01/2007 - 06/2006
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2007 - 06/2006
2SteroidsIBA
06/2006 - 07/2003
1Odorant Receptors (Odorant Receptor)IBA
07/2023
1Analgesics (Analgesic Drugs)IBA
06/2023
1Bradykinin B2 ReceptorIBA
06/2023
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
06/2023

Therapy/Procedure

15Therapeutics
07/2022 - 07/2003
3Renal Dialysis (Hemodialysis)
08/2021 - 01/2016
2Drug Therapy (Chemotherapy)
01/2020 - 11/2015
1Immunotherapy
01/2024
1Aftercare (After-Treatment)
06/2023